Biography
Gokul Das, Ph.D, is currently Professor of Oncology, Department of Pharmacology & Therapeutics at the Roswell Park Comprehensive Cancer Center (RPCCC) in Buffalo, NY. He is the Co-Director of Breast Translational Research Group (TRG) at Roswell and member of the graduate faculty at the University at Buffalo/UB (State University of New York/SUNY at Buffalo). Dr. Das obtained PhD in Molecular Biology and Pharmacology from Baylor College of Medicine, Texas Medical Center, Houston, followed by postdoctoral fellowship at the Cold Spring Harbor Laboratory, New York. He is a passionate researcher and teacher.
For the past three decades, Dr. Das’s research has focused on understanding and exploiting molecular mechanisms of cancer to develop effective therapeutic strategies. He has successfully translated innovative research findings from his laboratory to clinical trials in breast cancer patients in collaboration with clinicians. Dr. Das has published in high impact journals and his research has been funded by governmental and non-governmental granting agencies.
Research Interests
Interaction between estrogen receptors and tumor suppressor protein p53 signaling in breast cancer: understanding molecular mechanisms and identifying new prognostic markers and therapeutic targets, Role of p53 and estrogen receptor beta in non-small cell lung cancer (NSCLC) pathology, Cellular and molecular underpinnings of the role of estrogen receptors and mutant p53 in high grade serous ovarian cancer (HGSOC), Estrogen receptors and p53 in the regulation of nuclear-mitochondrial communication and energy metabolism, Clinical trials to translate research findings from the laboratory